NCT07601022

Brief Summary

To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
57mo left

Started May 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Dec 2030

Study Start

First participant enrolled

May 8, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

4.7 years

First QC Date

May 15, 2026

Last Update Submit

May 15, 2026

Conditions

Acute Heart Failure (AHF)

Keywords

acute heart failureheart failureelectrocardiography

Outcome Measures

Primary Outcomes (1)

  • 1-year mortality

    From enrollment to 1-year

Secondary Outcomes (1)

  • LVEF change

    From enrollment to 1-year

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute heart failure who were admitted to the hospital

You may qualify if:

  • Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
  • NT-proBNP ≥300 pg/mL ③ Patients who underwent electrocardiography at least once

You may not qualify if:

  • History of congenital heart disease ② Patients with a dominant electronic pacemaker rhythm ③ Patients with a heart rate \>140 beats per minute or electrocardiograms with excessive noise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 15, 2026

First Posted

May 22, 2026

Study Start

May 8, 2026

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

KR(1)